Skip to main content
SpringerLink
Log in

Mood Stabilizers

  • Chapter
  • First Online:
Psychiatric Drugs in Children and Adolescents

Abstract

The term “mood stabilizer” refers to a class of pharmacological agents primarily employed in the treatment of bipolar disorder, a subcategory of affective disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literature

Selected Literature

  • Amaladoss A, Roberts N, Amaladoss F (2010) Evidence for use of mood stabilizers and anticonvulsants in the treatment on nonaffective disorders in children and adolescents. Clin Neuropharmacol 33:303–11

    Article  CAS  PubMed  Google Scholar 

  • Annell AL (1969) Manic-depressive illness in children and effect of treatment with lithium carbonate. Acta Paedopsychiatr 36:292–301

    CAS  PubMed  Google Scholar 

  • Biederman J, Joshi G, Mick E, Doyle R, Georgiopoulos A, Hammerness P, Kotarski M, Williams C, Wozniak J (2010) A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder. CNS Neurosci Ther 16:91–102

    Article  CAS  PubMed  Google Scholar 

  • Bostwick JM, Pankratz VS (2000) Affective disorders and suicide risk: a reexamination. Am J Psychiatry 157:1925–32

    Article  CAS  PubMed  Google Scholar 

  • Cole N, Parker G (2012) Cade’s identification of lithium for manic-depressive illness – the prospector who found a gold nugget. J Nerv Ment Dis 200:1101–4

    Article  PubMed  Google Scholar 

  • Correll C, Carlson HE (2008) Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. J Am Acad Child Adolesc Psychiatry 45:771–91

    Article  Google Scholar 

  • DelBello MP, Findling RL, Kushner S, Wang D, Olson WH, Capece JA, Fazzio L, Rosenthal NR (2005) A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:539–47

    Article  PubMed  Google Scholar 

  • Findling RL, McNamara NK, Gracious BL, Youngstrom EA, Stansbrey RJ, Reed MD, Demeter CA, Branicky LA, Fisher KE, Calabrese JR (2003) Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry 42:895–901

    Article  PubMed  Google Scholar 

  • Findling RL, McNamara NK, Youngstrom EA, Stansbrey R, Gracious BL, Reed MD, Calabrese JR (2005) Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:409–17

    Article  PubMed  Google Scholar 

  • Findling RL, McNamara NK, Stansbrey R, Gracious BL, Whipkey RE, Demeter CA, Reed MD, Youngstrom EA, Calabrese JR (2006) Combination lithium and divalproex sodium in pediatric bipolar symptom restabilization. J Am Acad Child Adolesc Psychiatry 45:142–48

    Article  PubMed  Google Scholar 

  • Findling RL, Kafantaris V, Pavuluri M, McNamara NK, Frazier JA, Sikich L, Kowatch R, Rowles BM, Clemons TE, Taylor-Zapata P (2013) Post-acute effectiveness of lithium in pediatric bipolar I disorder. J Child Adolesc Psychopharmacol 23:80–90

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Fountoulakis KN, Kasper S, Andreassen O, Blier P, Okasha A, Severus E, Versiani M, Tandon R, Möller H-J, Vieta E (2012) Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. Eur Arch Psychiatry Clin Neurosci 262(Suppl 1):1–48

    Article  PubMed  Google Scholar 

  • Frye MA, Ketter TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA, Luckenbaugh DA, Corá-Locatelli G, Leverich GS, Post M (2000) A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 20:607–14

    Article  CAS  PubMed  Google Scholar 

  • Geller B, Couper TB, Sun K, Zimerman B, Frazier J, Williams M, Heath J (1998) Double-blind- and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 37:171–8

    Article  CAS  PubMed  Google Scholar 

  • Geller B, Luby JL, Joshi P, Wagner KD, Emslie G, Walkup JT, Axelson DA, Bolhofner K, Robb A, Wolf DV, Riddle MA, Birmaher B, Nusrat N, Ryan ND, Vitiello B, Tilman R, Lavori P (2012) A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Arch Gen Psychiatry 69:515–28

    Article  CAS  PubMed  Google Scholar 

  • Gerlach M, Warnke A (2010) Therapy with mood stabilizers in child and adolescent psychiatry. Psychopharmakotherapie 17:183–87

    Google Scholar 

  • Goldstein BI, Sassi R, Diler RS (2012) Pharmacologic treatment of bipolar disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am 21:911–39

    Article  PubMed  Google Scholar 

  • Hachad H, Ragueneau-Majlessi I, Levy RH (2002) New antiepileptic drugs: review on drug interactions. Ther Drug Monit 24:91–103

    Article  CAS  PubMed  Google Scholar 

  • Hazell P, Jairam R (2012) Acute treatment of mania in children and adolescents. Curr Opin Psychiatry 25:264–70

    Article  PubMed  Google Scholar 

  • Hussein G, Troupin AS, Montouris G (1996) Gabapentin interaction with felbamate. Neurology 47:1106

    Article  CAS  PubMed  Google Scholar 

  • Joshi G, Wozniak J, Mick E, Doyle R, Hammerness P, Georgiopoulos A, Kotarski M, Aleardi M, Williams C, Walls S, Biederman J (2010) A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder. J Child Adolesc Psychopharmacol 20:7–14

    Article  PubMed  Google Scholar 

  • Kafantaris V, Coletti DJ, Dicker R, Padula G, Pleak RR, Alvir JMJ (2004) Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study. J Am Acad Child Adolesc Psychiatry 43:984–93

    Article  PubMed  Google Scholar 

  • Kowatch RA, Suppes T, Carmody TJ, Bucci JP, Hume JH, Kromelis M, Emslie GJ, Weinberg WA, Rush AJ (2000) Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 39:713–20

    Article  CAS  PubMed  Google Scholar 

  • Kowatch RA, Sethuraman G, Hume JH, Kromelis M, Weinberg WA (2003) Combination pharmacotherapy in children and adolescents with bipolar disorder. Biol Psychiatry 53:978–84

    Article  CAS  PubMed  Google Scholar 

  • Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M, The Child Psychiatric Workgroup on Bipolar Disorder (2005) Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:213–35

    Article  PubMed  Google Scholar 

  • Lenox RH, Hahn CG (2000) Overview of the mechanism of action of lithium in the brain: fifty-year update. J Clin Psychiatry 61(Suppl 9):5–15

    CAS  PubMed  Google Scholar 

  • Li J, Lu W-Q, Beesley S, Loudon ASI, Meng Q-J (2012) Lithium impacts on the amplitude and period of the molecular circadian clockwork. PLoS ONE 7:e33292

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Liu HY, Potter MP, Woodworth KY, Yorks DM, Petty CR, Wozniak JR, Faraone SV, Biederman J (2011) Pharmacologic treatment for pediatric bipolar disorder: a meta-analysis. J Am Acad Child Adolesc Psychiatry 50:749–62

    Article  PubMed  Google Scholar 

  • McClellan J, Kowatch R, Findling RL (2007) Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 46:107–25

    Article  PubMed  Google Scholar 

  • McElroy SL, Keck PE, Pope HG, Hudson JI, Faedda GL, Swann AC (1992) Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 149:1633–44

    CAS  PubMed  Google Scholar 

  • Messenheimer J (2002) Efficacy and safety of lamotrigine in pediatric patients. J Child Neurol 17(Suppl 2):2S34–2S42

    PubMed  Google Scholar 

  • Nevels RM, Dehon EE, Alexander K, Gontkovsky ST (2010) Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: a review of current and potentially promising treatment options. Exp Clin Psychopharmacol 18:184–201

    Article  PubMed  Google Scholar 

  • Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G, Gabapentin Bipolar Disorder Study Group (2000) Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Bipolar Disord 2:249–55

    Article  CAS  PubMed  Google Scholar 

  • Patel NC, Delbello MP, Bryan HS, Adler CM, Kowatch RA, Stanford K, Strakowski SM (2006) Open-label lithium for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 45:289–97

    Article  PubMed  Google Scholar 

  • Pavuluri MN, Henry DB, Carbray JA, Sampson G, Naylor MW, Janicak PG (2004) Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. J Affect Disord 82:S103–11

    Article  CAS  PubMed  Google Scholar 

  • Pavuluri MN, Henry DB, Carbray JA, Sampson GA, Naylor MW, Janicak PG (2006) A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder. J Child Adolesc Psychop Pharmacol 16:336–50

    Article  Google Scholar 

  • Schatzberg AF, Cole JO, de Battista C (2003) Manual of clinical psychopharmacology, 4th edn. American Psychiatric Publishing, Washington

    Google Scholar 

  • Schloesser RJ, Martinowich K, Manji HK (2012) Mood-stabilizing drugs: mechanism of action. Trends Neurosci 35:36–46

    Article  CAS  PubMed  Google Scholar 

  • Tramontina S, Zeni CP, Pheula G, Rohde LA (2007) Topiramate in adolescents with juvenile bipolar disorder presenting weight gain due to atypical antipsychotics or mood stabilizers: An open clinical trial. J Child Adolesc Psychopharmacol 17:129–34

    Article  PubMed  Google Scholar 

  • Wagner KD, Kowatch RA, Emslie GJ, Findling RL, Wilens TE, McCague K, D’Souza J, Wamil A, Lehman RB, Berv D, Linden D (2006) A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry 163:1179–86

    Article  PubMed  Google Scholar 

  • Wagner KD, Redden L, Kowatch RA, Wilens TE, Segal S, Chang K, Wozniak P, Vigna NV, Abi-Saab W, Saltarelli M (2009) A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 48:519–32

    Article  PubMed  Google Scholar 

  • Weiss SRB, Post RM (1998) Kindling: separate vs. shared mechanisms in affective disorders and epilepsy. Neuropsychobiology 38:167–80

    Article  CAS  PubMed  Google Scholar 

Further Reading

  • Altamura AC, Lietti L, Dobrea C, Benatti B, Arici C, Dell’Osso B (2011) Mood stabilizers for patients with bipolar disorder: the state of the art. Expert Rev Neurother 11:85–99

    Article  PubMed  Google Scholar 

  • Chiu C-T, Wang Z, Hunsberger JG, Chuang D-M (2013) Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev 65:105–42

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Licht RW (2012) Lithium: still a major option in the management of bipolar disorder. CNS Neurosci Ther 18:219–26

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Laboratory for Clinical Neurobiology and Therapeutic Drug Monitoring, University of Würzburg, Füchsleinstr.15, 97080, Würzburg, Germany

    Manfred Gerlach PhD

  2. Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Füchsleinstr.15, 97080, Würzburg, Germany

    Andreas Warnke MD

Authors
  1. Manfred Gerlach PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreas Warnke MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manfred Gerlach PhD .

Editor information

Editors and Affiliations

  1. Kinder- und Jugendpsychiatrie, Universitätsklinikum Würzburg Klinik und Poliklinik, Würzburg, Germany

    Manfred Gerlach

  2. Jugendpsychiatrie und Psychotherapie, Universitätsklinikum Würzburg Klinik und Poliklinik für Kinder- und, Würzburg, Germany

    Andreas Warnke

  3. Child and Adolescent Psychiatry New York Presbyterian Hospital, New York, New York, USA

    Laurence Greenhill

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Wien

About this chapter

Cite this chapter

Gerlach, M., Warnke, A. (2014). Mood Stabilizers. In: Gerlach, M., Warnke, A., Greenhill, L. (eds) Psychiatric Drugs in Children and Adolescents. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1501-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-1501-5_7

  • Published:

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-1500-8

  • Online ISBN: 978-3-7091-1501-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation